Interchangeability of PD-L1 Laboratory-Developed Test by 22C3 Antibody Concentrate Among Ihc Platforms in Gastric Cancer

Pathology - United States
doi 10.1016/j.pathol.2020.01.408
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Using 22C3 Anti-Pd-L1 Antibody Concentrate on Biopsy and Cytology Samples From Non-Small Cell Lung Cancer Patients

Journal of Visualized Experiments
ImmunologyMolecular BiologyBiochemistryMicrobiology Chemical EngineeringNeuroscienceGenetics
2018English

P2.09-08 Clinical Outcomes of Histology Versus Cytology PD-L1 22C3 Antibody Testing in Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Clinicopathological Features of 22C3 PD-L1 Expression With Mismatch Repair, Epstein–Barr Virus Status, and Cancer Genome Alterations in Metastatic Gastric Cancer

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
2018English

EBV-associated Gastric Cancer Evades T-Cell Immunity by PD-1/PD-L1 Interactions

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
2018English

P1.09-05 Why Does PD-L1 (22C3) Expression Rate Show Difference Among Regional Hospitals?

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Mutations Defining Patient Cohorts With Elevated PD-L1 Expression in Gastric Cancer

Frontiers in Pharmacology
Pharmacology
2019English

Rationale of Combination of Anti-Pd-1/Pd-L1 Antibody Therapy and Radiotherapy for Cancer Treatment

International Journal of Clinical Oncology
MedicineSurgeryOncologyHematology
2020English

P3.09-02 Utilization of Laboratory Developed Tests for PD-L1 Evaluation Is Dependent on Tumor Type

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

PC06.02 Laboratory Developed Test - CON

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy